The Effects of Dietary Supplementation on Serum Protein Glycosylation (NCT05040204)
🩺 Plain-English Summary (8th-Grade Level)
Two randomized double-blind placebo-controlled clinical studies to assess the effects of dietary glycan monomer supplementation on the immune system, especially antibody glycosylation in healthy adults. Immune profiling and glycoproteomics will be performed on serum isolated at these same time points.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (1 items) and avoid the listed exclusions (32 items).
Location: University of California, Davis Medical Center — Sacramento, California
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Adults younger than 18 or older than 45 years of age
- Women who are pregnant, actively nursing or have had a pregnancy within the last year
- Women who are peri-menopausal or post-menopausal
- Women with irregular menstrual cycles (more frequently than every 21 days or lasts longer than 8 days. Missed, early, or late periods are also considered signs of an irregular cycle)
- Women on hormonal contraception, including birth control, hormonal intrauterine device, or contraceptive implant
- Individuals with past medical history of an autoimmune condition or malignancy, excluding non-melanoma skin cancer
- Individuals with cardiovascular, pulmonary, reproductive, endocrine, metabolic, neurologic, gastrointestinal, hematologic, or infectious diseases of any type
- Individuals with diagnosis of galactosemia or congenital disorders of glycosylation
- Individuals with phenylketonuria
- Individuals currently taking prescription medications, or who have taken prescription medications within the last 3 months
- Individuals currently taking over-the-counter medications
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (1 Sites)
- University of California, Davis Medical Center — Sacramento, California
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.